Sanofi’s Tzield gains pediatric approval but can early intervention truly change T1D outcomes
FDA expands Tzield use to young children with type 1 diabetes. Discover what this means for early intervention and long-term outcomes.
FDA expands Tzield use to young children with type 1 diabetes. Discover what this means for early intervention and long-term outcomes.